Last Thursday, a proposed regulation aimed at curbing the high levels of “off-label” uses for antipsychotic medications failed to pass the Senate. This proposed legislation relates back to a report last November by Daniel R. Levinson, the U.S. Inspector General, that exposed the high levels of antipsychotic medications administered to nursing facility residents. That report stated a... READ MORE
Posted on May 29, 2012 in Long-Term Care, Home Health & Hospice
Written by: Bufford, David W.